Trueblue (TBI) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
24 Dec, 2025Executive summary
Q4 2024 revenue declined 22% year-over-year (16% on a comparable basis), with net loss widening to $12 million and adjusted EBITDA rising to $9 million, as the company focused on agility, digital transformation, and strategic market expansion.
Full-year 2024 revenue was $1.6 billion, down 18% year-over-year (17% comparable), with a net loss of $126 million.
Expanded client relationships in logistics and technology, launched the proprietary JobStack app, and simplified the organization.
Acquired Healthcare Staffing Professionals (HSP) for $42 million, expanding into healthcare staffing, with up to $14 million additional consideration based on performance.
Secured a major multi-year contract with the U.K. Armed Forces and increased field sales representatives by 50% in a cost-neutral manner.
Financial highlights
Q4 2024 revenue was $386 million, down 22% year-over-year (16% comparable); full-year revenue was $1,567 million (-18% year-over-year; -17% comparable).
Gross margin improved to 26.6% in Q4, up 50 basis points, aided by lower workers' compensation costs.
Q4 net loss was $12 million; adjusted net loss was $1 million; adjusted EBITDA was $9 million, up 73% year-over-year.
SG&A reduced by 18% (24% on an adjusted basis), outpacing revenue decline; Q4 adjusted SG&A was $95 million.
Ended Q4 with $23 million in cash, $8 million in debt, and $119 million in borrowing availability.
Outlook and guidance
Q1 2025 revenue expected between $347 million and $374 million, down 13% to 7% year-over-year, with a positive 3-point impact from HSP and a 1-point headwind from the Canadian divestiture.
SG&A for Q1 2025 guided at $93–$97 million, about $12 million lower than prior year.
Segment revenue guidance: PeopleReady down ~16%, PeopleManagement down ~3%, PeopleScout down ~27%.
FY 2025 CapEx expected at $19–$23 million; minimal income tax expense anticipated.
Guidance assumes current market conditions persist and includes HSP acquisition impact.
Latest events from Trueblue
- Board refreshment and profitability initiatives advance as proxy contest with EHS continues.TBI
Proxy Filing3 Mar 2026 - Revenue up 8% to $418M, but net loss widened on impairment; margin pressure persists.TBI
Q4 202518 Feb 2026 - Q2 revenue down 17% to $396M, net loss $105M, with cost cuts and digital focus amid uncertainty.TBI
Q2 20242 Feb 2026 - Digital innovation and market expansion drive growth and margin gains in a fragmented staffing sector.TBI
Sidoti September Small-Cap Virtual Conference20 Jan 2026 - Q3 revenue dropped 19.2% with a $59.1M goodwill impairment and strong cost controls.TBI
Q3 202416 Jan 2026 - Board refreshment and strategic initiatives position the company for long-term growth.TBI
Proxy Filing9 Jan 2026 - Board refreshment and strategic focus highlighted as proxy process begins for 2026.TBI
Proxy Filing9 Jan 2026 - Board appointments and refreshment aim to drive growth, oversight, and long-term value.TBI
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, executive pay, incentive plan, and auditor, with strong governance and ESG focus.TBI
Proxy Filing1 Dec 2025